Max Robotics — Global Service Robot Directory + US Certification

About

Simonetta Bianchi is a leading figure in breast cancer research, with a particular focus on preoperative radiotherapy and its integration with surgical oncology. Her work centers on refining treatment paradigms for early-stage breast cancer, specifically through the investigation of partial breast irradiation and robotic radiosurgery. As the principal investigator of the landmark phase II ROCK trial (NCT03520894), she demonstrated the feasibility and safety of preoperative robotic radiosurgery for early breast cancer, a study that has garnered 29 citations and reshaped discussions around targeted, non-invasive tumor bed treatment. Bianchi’s contributions extend to evaluating pathological response and optimizing patient selection for de-escalated radiotherapy protocols, bridging the gap between radiation oncology and breast-conserving surgery. Her research has been instrumental in advancing personalized, less toxic treatment approaches, earning her recognition as a key innovator in the field. With a career dedicated to translating clinical trial results into practice, Bianchi continues to influence how early breast cancer is managed, offering patients shorter, more precise treatment courses while maintaining excellent oncologic outcomes.